PubRank

J Swedenborg

Author PubWeight™ 55.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 3.21
2 Ruptured abdominal aortic aneurysms: a study of incidence and mortality. Br J Surg 1986 2.19
3 Little impact of elective surgery on the incidence and mortality of ruptured aortic aneurysms. Eur J Vasc Surg 1994 2.12
4 Survival in patients with abdominal aortic aneurysms. Comparison between operative and nonoperative management. Eur J Vasc Surg 1990 1.90
5 Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg 1995 1.76
6 Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 1995 1.51
7 Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg 2011 1.50
8 Regional variation in the incidence of abdominal aortic aneurysm in Sweden. Br J Surg 2012 1.43
9 Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 1995 1.32
10 Growth rate of abdominal aortic aneurysms as measured by computed tomography. Br J Surg 1985 1.21
11 Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000 1.15
12 Biomechanical rupture risk assessment of abdominal aortic aneurysms: model complexity versus predictability of finite element simulations. Eur J Vasc Endovasc Surg 2010 1.12
13 Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 2010 1.06
14 Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease. Eur J Vasc Surg 1993 1.00
15 Implantable catheter system for long-term intravenous chemotherapy. J Surg Oncol 1989 0.96
16 Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 2000 0.95
17 Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993 0.93
18 Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway. Mol Carcinog 1998 0.93
19 Septic false aneurysms. Report of three cases. Acta Chir Scand 1982 0.92
20 Early experience with transfemoral endovascular aneurysm management (TEAM) in the treatment of aortic aneurysms. Eur J Vasc Endovasc Surg 1996 0.87
21 Influence of perioperative blood glucose levels on outcome after infrainguinal bypass surgery in patients with diabetes. Br J Surg 2006 0.87
22 Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma. Scand J Clin Lab Invest Suppl 1985 0.86
23 Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology 1987 0.86
24 The impact of intraluminal thrombus failure on the mechanical stress in the wall of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2011 0.85
25 Changes in middle cerebral artery flow velocity and pulsatility index after carotid endarterectomy. Eur J Vasc Surg 1991 0.85
26 Platelet adhesiveness. J Surg Res 1975 0.83
27 Continuous assessment of local metabolism by microdialysis in critical limb ischaemia. Eur J Vasc Endovasc Surg 2000 0.83
28 Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells. Arterioscler Thromb 1994 0.82
29 Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity. Eur J Vasc Endovasc Surg 2000 0.82
30 Different disease profiles for women and men with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2007 0.81
31 Level of arterial obstruction in patients with peripheral arterial occlusive disease (PAOD) determined by laser Doppler fluxmetry. Eur J Vasc Surg 1993 0.81
32 Heparin-chitosan complexes stimulate wound healing in human skin. Scand J Plast Reconstr Surg Hand Surg 1997 0.81
33 The correlation of symptoms, occult blood tests, and neoplasms in patients referred for double-contrast barium enema. Scand J Gastroenterol 1993 0.80
34 Atherosclerotic occlusive disease after radiation for pelvic malignancies. Acta Chir Scand 1990 0.80
35 Inhibited platelet adhesion: a non-thrombogenic characteristic of a heparin-coated surface. Surgery 1974 0.80
36 Long and short term patency of radiocephalic arteriovenous fistulas. Acta Chir Scand 1988 0.80
37 Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition. Thromb Haemost 1987 0.79
38 Effects of local hyperemia and edema on the biological zero in laser Doppler fluxmetry (LD). Int J Microcirc Clin Exp 1992 0.79
39 The anatomic range of examination by fibreoptic rectosigmoidoscopy (60 centimetres). Scand J Gastroenterol 1992 0.78
40 Thrombectomy and temporary arterio-venous fistula for ilio-femoral venous thrombosis. Int Angiol 1988 0.78
41 Delayed lung lesion in dogs after thrombin-induced disseminated intravascular coagulation. Acta Chir Scand 1974 0.78
42 Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta. Arterioscler Thromb Vasc Biol 1996 0.78
43 [Clinical assessment of critical ischemia is always to be done prior to amputation]. Lakartidningen 1999 0.78
44 In vitro endothelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow. J Thorac Cardiovasc Surg 2001 0.78
45 The efficacy of transfemoral endovascular aneurysm management: a study on size changes of the abdominal aorta during mid-term follow-up. Eur J Vasc Endovasc Surg 1997 0.78
46 Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall. Thromb Res 1983 0.77
47 The vascular endothelium as an inhibitor of thrombin. Thromb Res Suppl 1983 0.77
48 Uptake and inhibition of thrombin by the vascular wall. Thromb Res 1982 0.77
49 Acute ischemia of the extremities in a metropolitan area during one year. J Cardiovasc Surg (Torino) 1985 0.77
50 The influence of reactive hyperemia and leg dependency on skin microcirculation in patients with peripheral arterial occlusive disease (PAOD), with and without diabetes. Vasa 1990 0.77
51 Cultured human endothelial cells seeded on expanded polytetrafluoroethylene support thrombin-mediated activation of protein C. J Vasc Surg 1996 0.77
52 Outcome after abdominal aortic aneurysm repair. Difference between men and women. Eur J Vasc Endovasc Surg 2004 0.76
53 Thrombin inactivation on surfaces with covalently bonded heparin. Thromb Res 1986 0.76
54 Complications in carotid endarterectomy are predicted by qualifying symptoms and preoperative CT findings. Eur J Vasc Endovasc Surg 1999 0.76
55 [Approved implants are not always carefully tested]. Lakartidningen 1995 0.75
56 [Surgical or non-surgical abdominal aortic aneurysm--the choice of treatment is based on the size of the aneurysm]. Lakartidningen 1990 0.75
57 [Questioning a therapeutic proposal for bleeding disorders]. Lakartidningen 1980 0.75
58 Surgery in patients with von Willebrand's disease. Br J Surg 1989 0.75
59 Evaluation of transluminal recanalisation of the femoral artery. Acta Chir Scand 1969 0.75
60 [Hemodynamic changes of adenosine diphosphate, adenosine triphosphate, and thrombin in relation to their platelet-aggregating activity]. Scand J Clin Lab Invest 1971 0.75
61 Inhibitory effect of polyphloretin phosphate upon platelet aggregation and hemodynamic and respiratory changes caused by thrombin and protamine. J Pharmacol Exp Ther 1974 0.75
62 Effect of defibrinogenation and acetylsalicylic acid on the circulatory response to thrombin. Acta Chir Scand 1972 0.75
63 Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br J Surg 2015 0.75
64 Blood and surface factors of importance for vascular surgery. Acta Chir Scand Suppl 1985 0.75
65 Effect of heparin on thrombin inhibition in the microcirculation. Thromb Haemost 1993 0.75
66 Interposition graft fistulas for hemodialysis. Acta Chir Scand 1988 0.75
67 Pancreatico-pleural fistulae. Presentation of a case and review of the literature. Ann Chir Gynaecol 1982 0.75
68 Increased biliary concentration of contrast media by combined oral and intravenous administration. Acta Radiol Diagn (Stockh) 1971 0.75
69 Uptake and inactivation of thrombin on rabbit aortic endothelium studied with two different substrates. Thromb Haemost 1985 0.75
70 [Vascular surgery after the year of 2000--challenges for the future]. Lakartidningen 2000 0.75
71 False aneurysm of axillary artery following resection of a traumatized humeral head: case report. J Trauma 1979 0.75
72 Polyphloretinphosphate, an antithrombogenic substance which inhibits platelet adhesion. Thromb Res 1974 0.75
73 Activation of plasma coagulation in vivo by epinephrine and platelet release reaction. An experimental study in the dog. Thromb Res 1978 0.75
74 Effects of disseminated intravascular coagulation on pulmonary circulation and respiration. Int Anesthesiol Clin 1972 0.75
75 Effect of acetyl salicylic acid on increased production of thromboxane after aortic graft surgery. Eur J Vasc Surg 1989 0.75
76 Thrombin-induced vasoconstriction in the pulmonary circulation. Scand J Clin Lab Invest 1971 0.75
77 [The peripheral vasodilator activity of thrombin]. Folia Haematol Int Mag Klin Morphol Blutforsch 1969 0.75
78 Acute nontraumatic extremity ischaemia in Sweden. A one-year survey. Acta Chir Scand 1985 0.75
79 Thrombin-induced vasodilatation and hypotension in dogs: role of fibrinogen, plasma kinins, and blood cells. Cardiovasc Res 1969 0.75
80 On the role of vasoactive substances in haemodynamic changes induced by thrombin. Acta Chir Scand 1971 0.75
81 Thrombogenicity of the injured vessel wall--role of antithrombin and heparin. Thromb Haemost 1994 0.75
82 Thrombin uptake and inhibition on endothelium and surfaces with a stable heparin coating: a comparative in vitro study. J Biomed Mater Res 1986 0.75
83 Long-term stability in vivo of a thromboresistant heparinized surface. Biomaterials 1987 0.75
84 Polyphloretine phosphate as an inhibitor of platelet adhesion. Comparison with acetylsalicylic acid and dipyridamole. Thromb Res 1977 0.75
85 Requirements for thromboresistance of surface-heparinized materials. Ann N Y Acad Sci 1983 0.75
86 Postocclusive reactive hyperemia estimating peripheral vascular resistance: a noninvasive method to predict outcome of infrainguinal vascular reconstructions? J Cardiovasc Surg (Torino) 1996 0.75
87 Carotid atherosclerosis in patients operated for lower extremity ischemia before the age of 50: a case control study. Ann Vasc Surg 1998 0.75
88 Infusion methods for determination of peripheral resistance: influence of infused medium and back pressure. Ann Vasc Surg 1994 0.75
89 Acute nontraumatic extremity ischemia. A review. Eur J Surg 1991 0.75
90 The toe pole test for evaluation of arterial insufficiency in diabetic patients. Eur J Vasc Endovasc Surg 1999 0.75
91 Inhibition of thrombin on subendothelium. Studies on rabbit aorta, ex vivo. Eur Surg Res 1989 0.75
92 Coagulation activity of surface activated plasma in vivo. Thromb Res 1979 0.75
93 Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery. Eur J Vasc Surg 1992 0.75
94 The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2003 0.75
95 The role of adenine nucleotides in the peripheral vasodilating effect of thrombin. Acta Physiol Scand 1969 0.75
96 Coagulant and noncoagulant thrombin enzymatic activity on the endothelium. Blood Coagul Fibrinolysis 1990 0.75
97 Femoro-popliteal and femoro-distal bypass: a comparison between in situ and reversed technique. J Cardiovasc Surg (Torino) 1991 0.75
98 [An alternative treatment of carotid stenosis with transient ischemic attacks]. Lakartidningen 1982 0.75
99 Ruptured atherosclerotic aneurysm of the superficial femoral artery. Case report. Acta Chir Scand 1989 0.75
100 Proceedings: Decreased platelet adhesion as a characteristic of non-thrombogenic heparinized polymer surfaces. Thromb Diath Haemorrh 1975 0.75
101 The "ad hoc" estimation of outflow does not predict patency of infrainguinal reconstructions. Eur J Vasc Endovasc Surg 1995 0.75
102 Computed tomography in the pre-operative evaluation of abdominal aortic aneurysms. Vasa 1980 0.75
103 Thrombectomy and arteriovenous fistula for iliofemoral venous thrombosis in fertile women. Surg Gynecol Obstet 1982 0.75
104 Thrombin-inhibitory capacity of the injured vessel wall. Thromb Res 1991 0.75
105 Effects of slow defibrinogenation on the canine lung. J Trauma 1974 0.75
106 Correlation between peripheral vascular resistance and time to peak flow during reactive hyperaemia. Eur J Vasc Surg 1994 0.75
107 Intimal dissection of the renal artery following selective angiography. Report of two cases and review of the literature. Vasa 1979 0.75
108 Thrombin inactivation and the effects of antithrombin and heparin in a recirculating Langendorff preparation. Thromb Res 1992 0.75
109 The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease. Cardiovasc Intervent Radiol 2006 0.75
110 Acute thrombosis and embolism of the extremities: factors influencing the result of treatment. Acta Chir Scand 1982 0.75
111 Localized arterial occlusions in patients treated with pelvic field radiation for cancer. Cancer 1978 0.75
112 [Leg and foot ulcers. Rapid healing and reduced number of amputations with improved treatment]. Lakartidningen 1993 0.75
113 Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall. Thromb Res 1991 0.75
114 Vasoactivity of adenine nucleotides released in vitro from blood cells by thrombin. Acta Physiol Scand 1970 0.75
115 Haemodynamics of axillofemoral grafting in a case with normal inflow and outflow vessels. Br J Surg 1977 0.75
116 Endovascular treatment of atherosclerotic lower limb lesions using a PTFE-collared stent-graft. J Endovasc Ther 2000 0.75
117 [Treatment of acute deep venous thrombosis]. Lakartidningen 1983 0.75
118 Uptake and inactivation of thrombin on aortic endothelium and neo-intima. Eur Surg Res 1985 0.75
119 Inactivation of thrombin by the aortic endothelium. Thromb Haemost 1983 0.75
120 The long-term outcome of proximal vein thrombosis during pregnancy is not improved by the addition of surgical thrombectomy to anticoagulant treatment. Eur J Vasc Endovasc Surg 1996 0.75
121 The vascular endothelium as an inhibitor of thrombin. Thromb Res 1983 0.75
122 Uptake and inactivation of thrombin on the subendothelium: comparisons with endothelium. Thromb Res 1987 0.75
123 Infected pseudo-aneurysm of the femoral artery caused by a monitoring catheter. Burns Incl Therm Inj 1985 0.75
124 [Embolization caused by an air-gun missile presented diagnostic problems]. Lakartidningen 1989 0.75
125 Results of surgical treatment for iliofemoral venous thrombosis. Br J Surg 1986 0.75
126 Removal of neointimal hyperplasia in Dacron grafts by an oscillating ring stripper. Surg Gynecol Obstet 1988 0.75
127 Thrombin activity appearing on the vessel wall after trauma. Thromb Haemost 1985 0.75
128 Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. Res Exp Med (Berl) 1987 0.75
129 An improved microsurgical course for a mixed group of surgeons. World J Surg 1981 0.75